Characteristic imprint of single nucleotide polymorphisms in multiple sclerosis

Journal of Molecular Neuroscience

Volumn 38, Issue 2, 2009, Pages 166-172

  Szolnoki, Zoltan ^a,c   Kondacs, Andras ^a   Mandi, Yvette ^b   Somogyvari, Ferenc ^b  

^a Pandy Kalman County Hospital   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c H 5600 Békéscsaba ^*  (Hungary)

Author keywords

Multiple sclerosis; Myelin basic protein; Single nucleotide polymorphisms

Indexed keywords

DNA; MESSENGER RNA; MYELIN BASIC PROTEIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE LOCATION; GLIA CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NEUROIMAGING; NUCLEOTIDE SEQUENCE; RNA STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM; UNTRANSLATED REGION; GENETIC PREDISPOSITION; GENETICS; PATHOPHYSIOLOGY;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 69249222927     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-008-9142-y     Document Type: Article

References (15)

1. Ainger, K., Avossa, D., Diana, A. S., Barry, C., Barbarese, E., & Carson, J. H. (1997). Transport and localization elements in myelin basic protein mRNA. The Journal of Cell Biology, 138, 1077-1087. doi:10.1083/jcb.138.5.1077. (Pubitemid 27386457)
2. Bencsik, K., Rajda, C., Fuvesi, J., Klivenyi, P., Jardanhazy, T., Torok, M., et al. (2001). The prevalence of multiple sclerosis, distribution of clinical forms of the disease and functional status of patients in Csongrad County, Hungary. European Neurology, 46, 206-209. doi:10.1159/000050806. (Pubitemid 33135795)
3. Carson, J. H., Worboys, K., Ainger, K., et al. (1997). Translocation of myelin basic protein mRNA in oligodendrocytes requires microtubulus and kinesin. Cell Motility and the Cytoskeleton, 38, 318-328. doi:10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#. (Pubitemid 27521603)
4. Durelli, L., Verdun, E., Barbero, P., et al. (2002). Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomosed multicentre study (INCOME). Lancet, 359, 1453-1460. doi:10.1016/S0140-6736(02)08430-1. (Pubitemid 34457761)
5. Edan, G., Miller, D., Clanet, M., et al. (1997). Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomized multicenre study of active disease using MRI and clinical criteria. Journal of Neurology, Neurosurgery, and Psychiatry, 62, 112-118.
6. Komoly, S., Hudson, L. D., Webster, H. D., & Bondy, C. A. (1992). Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proceedings of the National Academy of Sciences of the United States of America, 89, 1894-1898. doi:10.1073/pnas.89.5.1894.
7. Kurtzke, J. F. (1993). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDDS). Neurology, 33, 1442-1452.
8. McDonald, W. I., Compston, A., Edan, G., et al. (2001). Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Annals of Neurology, 50, 121-127. doi:10.1002/ana.1032. (Pubitemid 32591472)
9. Miller, D. H., Barkhof, F., Berry, I., Kappos, L., Scotti, S., & Thompson, A. J. (1991). Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. Journal of Neurology, Neurosurgery, and Psychiatry, 54, 683-688.
10. Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215-1218. doi:10.1093/nar/16.3.1215.
11. Poser, C. M., Paty, D. W., Scheimberg, L., et al. (1983). New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology, 13, 227-231. doi:10.1002/ana.410130302. (Pubitemid 13158528)
12. Szolnoki, Z. (2007). Pathomechanism of leukoaraiosis: molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis). Neuromol. Med., 9, 21-33. doi:10.1385/NMM:9:1:21. (Pubitemid 44772273)
13. Szolnoki, Z., Kondacs, A., Mandi, Y., et al. (2007). A genetic variant in cytoskeleton motors amplifies susceptibility to leukoaraiosis in hypertensive smokers: gene-environmental interaction behind vascular white matter demyelinization. Journal of Molecular Neuroscience, 33, 173-179. doi:10.1007/s12031-007-0062-z. (Pubitemid 47574940)
14. Thompson, A. J., Montalban, X., Barkhof, F., et al. (2000). Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Annals of Neurology, 47, 831-835. doi:10.1002/1531-8249(200006)476<831::AID-ANA21>3.0.CO;2-H. (Pubitemid 30390209)
15. Tintoré, M., Rovira, A., Martinez, M. J., et al. (2000). Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR. American Journal of Neuroradiology, 21, 702-706.